{name}
{subtitle}
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~46 mi. (Marborn, Germany, +137 more cities)
facility
Universitatsklinikum Giessen und Marburg GmbH ( Site 0413)
Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
city
~46 mi. (Marborn, Germany, +74 more cities)
facility
Philipps-Universität Marburg, Klinik für Innere medizin, Hämatologie, Onkologie und Immunologie
condition
Acute Myeloid Leukemia, +4 more conditions
drug
decitabine, +1 more drug
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
city
~73 mi. (Gießen, Germany, +144 more cities)
facility
GSK Investigational Site
drug
carboplatin, +3 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
city
~73 mi. (Gießen, Germany, +75 more cities)
facility
Universitaetsklinikum Giessen und Marburg GmbH ( Site 0411)
drug
bleomycin, +9 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~76 mi. (Göttingen, Germany, +226 more cities)
facility
Universitaetsklinikum Goettingen ( Site 0345)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type